Pilot Study of Aerobic Exercise During Immune Checkpoint Inhibitor Therapy in Early-Stage TNBC

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT07216495
Status
Recruiting
Apply to this trial

Conditions

  • Aerobic Exercise
  • Early Stage Triple Negative Breast Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Exercise — OTHER
    Cardiorespiratory training via treadmill walking for 30 minutes; participants will be supervised by a trained exercise physiologist.

Study Details

To learn if participating in a supervised exercise program can help participants with early-stage TNBC who are receiving ICI therapy before undergoing breast surgery.

Key Dates

Start date
Feb 23, 2026
Status verified
Apr 2026
Primary completion
Oct 30, 2028
Completion
Oct 30, 2030

Study Design

Enrollment
33 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Acute cardiorespiratory exercise program
    consisting of 4 in-clinic exercise sessions

Primary Outcome Measure

Adherence [ Time Frame: Approximately 8 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
MD Anderson Cancer CenterHoustonTexas77030
Jasmine Sukumar, MD
[email protected]
713-264-1576
Jasmine Sukumar, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By research site
MD Anderson Cancer Center· Houston, TX

Related Studies